BenevolentAI announces participation in upcoming investor conferences

/PRNewswire/ -- BenevolentAI (Euronext Amsterdam: BAI), a leading clinical-stage AI drug discovery company, today announces that it will participate in the...

Related Keywords

New York ,United States ,Rancho ,Netherlands General ,Netherlands ,London ,City Of ,United Kingdom ,Amsterdam ,Noord Holland ,Palos Verdes ,Eli Lilly ,Fleur Wood ,Prnewswire Benevolentai Euronext ,Morgan Stanley ,Goldman Sachs ,Drug Development ,Euronext Amsterdam ,Annual Global Healthcare Conference ,Rancho Palos Verdes ,Biotech Conference ,Tech Enabled Drug Development ,Benevolentai ,